DIM.FP Sartorius Stedim Biotech Loading...

Loading chart...
Top Calls
Feed
All Sources✓
YouTube✓
Twitter✓
Reddit✓
Substack✓
Insider✓
News✓
Loading...
All directions✓
▲ Long✓
▼ Short✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
01:01
May 01
TheLAPurchaser L/S Equity trader
Buy Sartorius on bioprocessing recovery, on-shoring CAPEX, biosimilar volume growth, AI drug innovation tailwinds, and reset multiples – revenue inflection expected CY27.
DIM.FP
HIGH
14:52
Apr 23
TheLAPurchaser L/S Equity trader
Buy DIM.FP as the recent selloff is overdone given high single-digit business growth, an equipment tailwind, and an attractive valuation, despite potential multiple compression from weak sector bellwethers.
DIM.FP
MED
10:45
Apr 21
TheLAPurchaser L/S Equity trader
Long DIM.FP due to strong order growth in bioprocessing equipment (>30% in Q1), indicating a sustained recovery and acceleration in the bioprocessing thematic.
DIM.FP 1ST
MED

About DIM.FP Analyst Coverage

Buzzberg tracks DIM.FP (Sartorius Stedim Biotech) across 1 sources. 3 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 3 total trade ideas tracked.